Cancer treatment achieves amazing results.. Healing all who tried it
An experimental cancer drug has had an impressive success rate, appearing to treat nearly every patient in a clinical trial.
Dustarlimab was used in a trial at Memorial Sloan Kettering Cancer Center (MSKCC) in New York that treated all 18 participants for some form of rectal cancer.
Dustarlimab was given to 18 people with a type of rectal cancer every three weeks for six months in a study conducted at the center.
The drug appeared to clear up rectal cancer with minimal side effects, although scientists say it's too early to say whether patients have been completely cured.
Participants were studied over a year of treatment, with the overall result appearing that the cancer was gone.
After the new treatment, all patients found their cancer was gone on a physical exam, endoscopy, PET scan and MRI, the MSKCC researchers said.
"I think this is the first time this has happened in the history of cancer," Dr. Luis Diaz, one of the paper's lead authors and an oncologist at MSKCC, told the New York Times.
This is a huge step forward for patients.”
He added that he believed this was just the "tip of the iceberg", according to "Mirror".
Dr. Hana Sanoff, of the University of North Carolina Leinberger Comprehensive Cancer Center, commented on the results of the study by saying that she is strongly optimistic about the new treatment, noting that "we've never seen anything that works for 100% of people in cancer medicine." of drugs called immune checkpoint inhibitors.
These are immunotherapy drugs that don't work by directly attacking the cancer itself but actually make a person's immune system do the work primarily."
Follow our latest local and sports news and the latest political and economic developments via Google news